A case report of persistent lateral branch of primitive maxillary artery infundibulum misdiagnosed as internal carotid artery aneurysm.

Persistent lateral branch of primitive maxillary artery is a rare anatomical variant of ophthalmic artery. It has significant implications in surgical and neurointerventional procedures because it can lead to diagnostic errors and procedural complications if misinterpreted. In this report, we presented a case of infundibular dilatation at the origin of persistent lateral branch of primitive maxillary artery, which was misdiagnosed as an internal carotid artery aneurysm and referred to our centre for embolization.

Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing : A Comparative Evaluation Using the CLSI and EUCAST Methods.

: The combination of aztreonam (ATM) and avibactam (AVI) presents an important therapeutic option for carbapenem-resistant , particularly the NDM-producing . In 2024, both the CLSI and EUCAST published their methods in antimicrobial susceptibility testing for this combination of agents. : Forty carbapenem-resistant isolates, including ( = 35), complex ( = 2), complex ( = 2), and complex ( = 1) were included in this study.

Towards new forms of communication and surveillance: a mixed methods study of rapid respiratory virus assessment in general practice during the SARS-CoV-2 pandemic.

Introduction Improvements in diagnostic test accuracy across multiple pathogens have resulted in multi-viral point-of-care testing (POCT) via a rapid antigen test (RAT). Aim This study aimed to describe general practice practitioners' reactions to a pilot respiratory virus surveillance programme during the SARS-CoV-2 pandemic, which enabled surveillance for influenza and other respiratory viruses alongside POCT for SARS-CoV-2. Methods Participating general practices collected viral swabs between May and December 2022.

Paediatric Utilisation of Ophthalmic Antibiotics in the Ear in Aotearoa/New Zealand.

Background/objectives: Some ophthalmic antibiotics are publicly subsidised in New Zealand (NZ) for off-label use in the ear, however, this utilisation has not previously been described. This study compared the utilisation of ophthalmic chloramphenicol and ciprofloxacin in the eye and ear, among NZ children.

Methods: This study involved clinical record review, and included 11,617 prescriptions of ophthalmic chloramphenicol and ciprofloxacin in 2022, for children aged five years or under in Auckland, NZ.